secwatch.observer — SEC 8-K summary
======================================

Issuer:     Jade Biosciences, Inc. (JBIO)
CIK:        0001798749
Form:       8-K
Filed at:   2024-10-10T23:59:59+00:00
Accession:  0001798749-24-000052
Event type: leadership
Sentiment:  neutral
Materiality: 0.30
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Director Maha Katabi resigns from Aerovate board and committees effective Oct 6, 2024
--------------------------------------------------------------------------------

- Maha Katabi, Ph.D., resigned from the board, Audit Committee, and Compensation Committee.
- Resignation effective October 6, 2024, voluntary and not due to any disagreement with the company.
- Board expressed gratitude for Dr. Katabi's service and contributions.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1798749/000179874924000052/0001798749-24-000052-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1798749/000179874924000052/tmb-20241006x8k.htm
  HTML page:      https://secwatch.observer/filing/0001798749-24-000052

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer